D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 25,242 464 World Ranking 11742 National Ranking 6241

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Cancer, Prostatectomy and Surgery. His Prostate cancer study combines topics from a wide range of disciplines, such as Prostate, Disease and Urology. His biological study spans a wide range of topics, including Gynecology and Oncology.

Matthew R. Cooperberg has researched Cancer in several fields, including Antigen, Epidemiology and Family medicine. Matthew R. Cooperberg has included themes like Cohort study, Prostate neoplasm, Nomogram, Hazard ratio and Radiation therapy in his Prostatectomy study. His study looks at the relationship between Surgery and fields such as Intensive care medicine, as well as how they intersect with chemical problems.

His most cited work include:

  • The Molecular Taxonomy of Primary Prostate Cancer (1426 citations)
  • Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer (781 citations)
  • The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary Management (508 citations)

What are the main themes of his work throughout his whole career to date?

Matthew R. Cooperberg mainly investigates Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate. His Prostate cancer research incorporates themes from Biopsy, Gynecology and Surgery. His Androgen deprivation therapy, Hazard ratio, Disease and Metastasis study, which is part of a larger body of work in Internal medicine, is frequently linked to Risk assessment, bridging the gap between disciplines.

His research investigates the connection between Oncology and topics such as Sipuleucel-T that intersect with issues in Asymptomatic. His Prostatectomy research is multidisciplinary, incorporating elements of Radiation therapy, Proportional hazards model, Cohort and Urology. Matthew R. Cooperberg interconnects Quality of life and Cohort study in the investigation of issues within Cancer.

He most often published in these fields:

  • Prostate cancer (77.42%)
  • Internal medicine (55.54%)
  • Oncology (43.90%)

What were the highlights of his more recent work (between 2018-2021)?

  • Prostate cancer (77.42%)
  • Internal medicine (55.54%)
  • Oncology (43.90%)

In recent papers he was focusing on the following fields of study:

Matthew R. Cooperberg mainly focuses on Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate. His research on Prostate cancer concerns the broader Cancer. His work in Oncology covers topics such as Castration resistant which are related to areas like Overall survival.

As a member of one scientific family, Matthew R. Cooperberg mostly works in the field of Prostatectomy, focusing on Body mass index and, on occasion, Obesity. His study in the field of Prostate biopsy is also linked to topics like TMPRSS2. The Watchful waiting study combines topics in areas such as Prostate-specific antigen and Cohort study.

Between 2018 and 2021, his most popular works were:

  • Association of Black Race with Prostate Cancer-Specific and Other-Cause Mortality (84 citations)
  • Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. (71 citations)
  • The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target (52 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of study are Prostate cancer, Internal medicine, Prostatectomy, Oncology and Prostate. Prostate cancer is a subfield of Cancer that Matthew R. Cooperberg tackles. His Cancer research incorporates elements of Urology and Intensive care medicine.

His Prostatectomy research includes elements of Prospective cohort study, Obesity, Proportional hazards model and Veterans Affairs. His work in the fields of Oncology, such as Overall survival, overlaps with other areas such as Food and drug administration. His research in Prostate intersects with topics in RNA, Biopsy and Comorbidity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell (2015)

1243 Citations

Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer

Matthew R. Cooperberg;Jeanette M. Broering;Peter R. Carroll.
Journal of Clinical Oncology (2010)

993 Citations

The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary Management

Matthew R. Cooperberg;Deborah P. Lubeck;Maxwell V. Meng;Shilpa S. Mehta.
Journal of Clinical Oncology (2004)

627 Citations

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll.
European Urology (2012)

624 Citations

Renal cell cancer stage migration: analysis of the National Cancer Data Base.

Christopher J. Kane;Katherine Mallin;Jamie Ritchey;Matthew R. Cooperberg.
Cancer (2008)

569 Citations

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

Eric A. Klein;Matthew R. Cooperberg;Cristina Magi-Galluzzi;Jeffry P. Simko.
European Urology (2014)

552 Citations

Trends in Management for Patients With Localized Prostate Cancer, 1990-2013

Matthew R. Cooperberg;Peter R. Carroll.
JAMA (2015)

508 Citations

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

Matthew R. Cooperberg;David J. Pasta;Eric P. Elkin;Mark S. Litwin.
The Journal of Urology (2005)

488 Citations

Contemporary trends in low risk prostate cancer: risk assessment and treatment.

Matthew R. Cooperberg;Jeannette M. Broering;Philip W. Kantoff;Peter R. Carroll.
The Journal of Urology (2007)

483 Citations

THE CONTEMPORARY MANAGEMENT OF PROSTATE CANCER IN THE UNITED STATES: LESSONS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR (CAPSURE), A NATIONAL DISEASE REGISTRY

Matthew R. Cooperberg;Jeanette M. Broering;Mark S. Litwin;Deborah P. Lubeck.
The Journal of Urology (2004)

476 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Matthew R. Cooperberg

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 175

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 173

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 132

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 129

Paul L. Nguyen

Paul L. Nguyen

Brigham and Women's Hospital

Publications: 124

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 119

Quoc-Dien Trinh

Quoc-Dien Trinh

Brigham and Women's Hospital

Publications: 115

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 108

Eric A. Klein

Eric A. Klein

Cleveland Clinic

Publications: 106

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 103

R. Jeffrey Karnes

R. Jeffrey Karnes

Mayo Clinic

Publications: 97

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 94

Anthony V. D'Amico

Anthony V. D'Amico

Brigham and Women's Hospital

Publications: 91

Mark Emberton

Mark Emberton

University College London

Publications: 90

James A. Eastham

James A. Eastham

Memorial Sloan Kettering Cancer Center

Publications: 87

Laurence Klotz

Laurence Klotz

Sunnybrook Health Science Centre

Publications: 85

Something went wrong. Please try again later.